BALCHEM CORP

UNITED STATES

SECURITIES AND EXCHANGE COMMISSION

Washington, D.C. 20549

SCHEDULE 14A

Proxy Statement Pursuant to Section 14(a)

of the Securities Exchange Act of 1934

(Amendment No. )

Filed by the Registrant ☒

Filed by a Party other than the Registrant☐

Check the appropriate box:

☐Preliminary Proxy Statement

☐Confidential, for Use of the Commission Only (as permitted by Rule 14a-6(e)(2))

☒Definitive Proxy Statement

☐Definitive Additional Materials

☐Soliciting Material Pursuant to §240.14a-12

BALCHEM CORPORATION

(Name of Registrant as Specified In Its Charter)

(Name of Person(s) Filing Proxy Statement, if other than the Registrant)

Payment of Filing Fee (Check the appropriate box):

LETTER TO SHAREHOLDERS

April 27, 2026

Dear Fellow Shareholders:

I am pleased to invite you to join us for Balchem Corporation’s (“Balchem”) 2026 Annual Meeting of Shareholders (the “Annual Meeting”), which will take place on June 18, 2026, at 8:30 a.m. Eastern Daylight Time.

Our Annual Meeting will continue to be held virtually. It will be conducted via live webcast, and shareholders may attend online by logging in atwww.virtualshareholdermeeting.com/BCPC2026. Using this website, you will be able to listen, vote, and submit questions.

The enclosed 2026 Proxy Statement and Notice of Annual Meeting describe the items of business that we will conduct at the meeting and provide you with important information about Balchem, including our practices in the areas of corporate governance and executive compensation. We strongly encourage you to read these materials and then vote your shares.

It is important that your shares be represented at the Annual Meeting and voted in accordance with your wishes. Whether or not you plan to attend the Annual Meeting, we urge you to authorize a proxy as promptly as possible — by Internet, telephone, or mail — so that your shares will be voted at the Annual Meeting. Instructions for voting are contained in the Notice of Internet Availability of Proxy Materials, and on page 3 of the attached Proxy Statement.

At the Annual Meeting we ask for your vote to:

The Board of Directors (the “Board”) unanimously recommends that you vote FOR all of the director nominees listed in the attached Proxy Statement, FOR the ratification of the appointment of RSM US LLP as our independent registered public accounting firm for the fiscal year ending December 31, 2026, and FOR the advisory approval of the compensation of our named executive officers’ compensation, all as disclosed in the attached Proxy Statement.

Our Board plays a pivotal role in overseeing the development and execution of our business strategy, risk management, and corporate governance. They continue to monitor best practices in corporate governance, sustainability, and executive compensation and via our ongoing shareholder engagement efforts, we continue to solicit input from our shareholders on these important topics. Over the last year, we adopted an Artificial Intelligence (“AI”) Use Policy and AI governance structure, recognizing that AI tools can help increase employee productivity and innovation when used in a safe, ethical, and secure manner. Our Board and management also engaged in cybersecurity tabletop exercises as part of our ongoing cybersecurity training efforts.

We hope you’ll join us at our Annual Meeting of Shareholders on June 18. Thank you for your continued support and confidence in Balchem as we advance our vision of “making the world a healthier place.”

Sincerely,

Table of Contents